Singapore markets closed
  • Straits Times Index

    3,101.93
    +9.82 (+0.32%)
     
  • Nikkei

    28,029.57
    +276.20 (+1.00%)
     
  • Hang Seng

    23,766.69
    -22.24 (-0.09%)
     
  • FTSE 100

    7,115.87
    -13.34 (-0.19%)
     
  • BTC-USD

    55,527.86
    -854.57 (-1.52%)
     
  • CMC Crypto 200

    1,406.80
    -34.96 (-2.43%)
     
  • S&P 500

    4,527.04
    -50.06 (-1.09%)
     
  • Dow

    34,461.94
    -177.85 (-0.51%)
     
  • Nasdaq

    15,056.13
    -325.19 (-2.11%)
     
  • Gold

    1,771.90
    +9.20 (+0.52%)
     
  • Crude Oil

    68.27
    +1.77 (+2.66%)
     
  • 10-Yr Bond

    1.4210
    -0.0270 (-1.86%)
     
  • FTSE Bursa Malaysia

    1,501.74
    0.00 (0.00%)
     
  • Jakarta Composite Index

    6,538.51
    -45.31 (-0.69%)
     
  • PSE Index

    7,055.19
    +22.65 (+0.32%)
     

2 Biotech Stocks Poised for Jaw-Dropping Growth

·5-min read
2 Biotech Stocks Poised for Jaw-Dropping Growth
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Over the past 10 years, U.S. stocks have delivered outstanding returns for investors. The major stock indices such as the Dow Jones Industrial Average, the NASDAQ Composite, and the S&P 500 have all climbed by more than 200% during this boom period. For example, biotech innovators Axsome Therapeutics (NASDAQ: AXSM) and Moderna (NASDAQ: MRNA), along with electric-car giant Tesla (NASDAQ: TSLA), have all generated well over 1,000% returns on capital for investors in just the past three years.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting